SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001095811-01-504260
Filing Date
2001-08-14
Accepted
2001-08-14 00:00:00
Documents
3
Period of Report
2001-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q QUARTERLY PERIOD ENDED JUNE 30, 2001 f74786e10-q.txt 10-Q 83448
3 EXHIBIT 10.18 f74786ex10-18.txt EX-10.18 14544
4 EXHIBIT 10.19 f74786ex10-19.txt EX-10.19 32669
  Complete submission text file 0001095811-01-504260.txt   132374
Mailing Address 3832 BAY CENTER PLACE HAYWARD CA 94545
Business Address 3832 BAY CENTER PL HAYWARD CA 94545 5106709300
LYNX THERAPEUTICS INC (Filer) CIK: 0000913275 (see all company filings)

IRS No.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22570 | Film No.: 1711463
SIC: 2833 Medicinal Chemicals & Botanical Products